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Intervention Project on Absence and Well-being (IPAW), Denmark
IPAW is a 5-year psychosocial work environment intervention study including 22 intervention and 30 control work places in three organisations (a large pharmaceutical company, municipal technical services and municipal nursing homes) in Copenhagen, Denmark. 7 The baseline questionnaire was posted to all the employees at the selected work-sites between 1996 and 1997. Of the 2 721 employees who worked at the 52 IPAW sites, 2 068 men and women completed the baseline questionnaire. Interventions took place at 22 workplaces during 1996-98 at the organisational and interpersonal level. IPAW was approved by and registered with the Danish Data Protection Agency (registration number: 2000-54-0066). Participants were provided information about the study and with the baseline questionnaire and responding was taken to imply informed consent to take part.
Swedish Longitudinal Occupational Survey of Health (SLOSH), Sweden
Swedish Longitudinal Occupational Survey of Health (SLOSH) is an on-going prospective cohort study following up individuals who participated in the Swedish Work Environment Survey (SWES) in 2003 or 2005. SWES, conducted biennially by Statistics Sweden, is based on a sample of gainfully employed people aged 16-64 years drawn from the Labour Force Survey (LFS). These individuals were first sampled into LFS through stratification by county, sex, citizenship and inferred employment status.
Data from the 2006 and 2008 data collection waves of SLOSH were used in the IPD-Work analyses. 8 In both years, data were collected using postal self-completion questionnaires. In 2006, 5 985 individuals responded to the questionnaires. In 2008, a further 6 751 individuals responded to the questionnaires. SLOSH has been approved by the Regional Research Ethics Board in Stockholm. The participants received written information about the study and, in accordance with Swedish regulation and practice, responding to and returning the survey indicated informed consent.
Whitehall II, UK
The Whitehall II study is a prospective cohort study set up to investigate socioeconomic determinants of health. At study baseline in 1985-1988, 10 308 civil service employees (6 895 men and 3 413 women) aged 35-55 and working in 20 civil service departments in London were invited to participate in the study 9 . The Whitehall II study protocol was approved by the University College London Medical School committee on the ethics of human research. Written informed consent was obtained at each data collection wave.
WOLF (Work, Lipids, and Fibrinogen) Stockholm and WOLF Norrland studies, Sweden
The WOLF (Work, Lipids, and Fibrinogen) Stockholm study is a prospective cohort study of 5 698 people (3 239 men and 2 459 women) aged 19-70 and working in companies in Stockholm county 10 . WOLF Norrland is a prospective cohort of 4 718 participants aged 19-65 working in companies in Jämtland and Västernorrland counties 11 . At study baseline the participants underwent a clinical examination and completed a set of health questionnaires. For WOLF Stockholm, the baseline assessment was undertaken at 20 occupational health units between November 1992 and June 1995 and for WOLF Norrland at 13 occupational health service units in 1996-98. The Regional Research Ethics Board in Stockholm, and the ethics committee at Karolinska Institutet, Stockholm, Sweden approved the study. The participants received written and verbal information about the study and participation was voluntary. Answering the baseline questionnaire was taken to imply informed consent to participate.
Baseline assessments
We calculated BMI as weight in kilograms divided by height in meters squared. Height and weight were measured (Whitehall II, WOLF N and WOLF S) or self-reported (DWECS, FPS, Gazel, HeSSup, HHS, IPAW and SLOSH). Participants with missing values for height or weight or BMI values <15 or >50 kg/m2 were excluded, as per prior analyses. 12 We classified BMI into five categories according to World Health Organization (WHO) recommendations.
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Participants with a BMI < 18·5 kg/m 2 were categorized as underweight, those with a BMI between 18·5 and <25 kg/m 2 were denoted as normal weight, and those with a BMI between 25 and <30 kg/m 2 as overweight. Individuals were classified as never, former or current smokers based on information extracted from participant questionnaires in all studies. 15 Physical activity at baseline was self-reported and differed between studies. 16 Some studies only had questions on sports activities and exercise, while for other studies information was also available for other types of leisure-time physical activities, such as walking and cycling. We constructed a measure of physical inactivity defined as no or very little, moderate or vigorous physical activity or exercise based on the best available information in each study. Examples of definitions of physical inactivity are "no weekly leisure-time physical activity," "no or very little exercise, only occasional walks," and "sport activities a few times per year or less." Individuals were categorized as physically active if they engaged in at least moderate levels of activity.
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Appendix 2: Definition of disease-free life-years Ascertainment of major noncommunicable diseases during follow-up
The outcome of interest in the present study was the first record of either incident type 2 diabetes, CHD, stroke, cancer, asthma or COPD. Participants with missing data on outcomes and participants with a record of any of these diseases at baseline were excluded from the analyses. We additionally excluded participants with a record of type 1 diabetes at baseline E10 (International Classification of Disease, revision 10 [ICD-10]) or 250 (ICD-9 and ICD-8).
1 Incident type 2 diabetes was identified via hospital discharge registers and mortality registers as the appearance of E11 (ICD-10) or 250 (ICD-9) in any of the diagnosis codes. Additionally, in the Finnish datasets (FPS, HeSSup, and HHS), incident type 2 diabetes was identified the first time the participant appeared in the nationwide drug reimbursement register as eligible for medication for this condition.2 In the Whitehall II study, type 2 diabetes was ascertained via 2-hour oral glucose tolerance test administered every 5 years 3 using World Health Organization criteria and complemented by self-reports of diabetes diagnosis and medication. 4 In the Gazel study, non-fatal cases were based on self-report from annual questionnaires. 1 Incident CHD and stroke during follow-up was identified from hospital discharge and mortality registers in all studies, except for Gazel, in which hospital register data were not available and non-fatal events were collected from annual self-report questionnaires. Incident non-fatal myocardial infarction or fatal coronary heart disease was defined by using the World Health Organization MONICA (Multinational Monitoring of Trends and Determinants in Cardiovascular Disease) Project criteria. 5 We included all non-fatal myocardial infarctions recorded as I21-I22 (ICD-10) or 410 (ICD-9), and coronary deaths I20-I25 (ICD-10) and 410-414 (ICD-9) in any of the diagnosis codes. Incident stroke was ascertained via hospital and mortality records; I60, I61, I63, I64 (ICD-10), 430, 431, 433, 434, 436 (ICD-9). 6, 7 Incident cancers, C00-C97 (ICD-10 any cancer) were identified via national cancer or mortality registers, except for Gazel, in which they were ascertained from the employer's medical register or by confirming any self-reported cancer diagnosis with the participant's physician. 8 Severe asthma and COPD exacerbations were ascertained from hospital discharge and death registers in all studies except for Gazel, in which non-fatal asthma events were based on self-report from annual questionnaires and non-fatal COPD was not available. Asthma was defined as J45 or J46 (ICD-10) or 493 (ICD-9) in any diagnostic code. 9 COPD was defined as J41, J42, J43 and J44 (ICD-10) or 491, 492 and 496 (ICD-9). The mean follow-up was 11·5 years (range between studies 6·3 -18·6). In men, 8159 had at least one incident disease during 543 522 person-years at risk. The corresponding figure was 8100 for women during 785 350 person-years at risk. As expected, the incidence of each chronic disease was higher in men than women (Supplemental Table 2 ). However, except for CHD women were diagnosed on average at a younger age than men.
Appendix 3: Study-specific analyses
The studies in supplementary figures 1 and 2 are sorted by baseline year. There was some heterogeneity between study-specific estimates, I 2 varied between 7·1% and 94·0%. The highest variation was found in categories of normal weight, overweight and obesity class I. The heterogeneity was not related to the baseline year of the study. No heterogeneity was observed in obesity class II and III. Despite heterogeneity, the overall pattern of greater loss of disease-free years with higher obesity was evident.
Supplemental figure 1 Study-specific estimates for men. 
Women
We first examined whether the use of pooled individual-level data across all studies was likely to be robust for a study of subgroups. To do so, we pooled the individual-level data and compared results from the pooled analysis with those obtained from the two-stage meta-analysis. Differences between estimates from the two analytic approaches were small (maximum 3·3 % -supplement table 3), suggesting that pooled analyses can be used in stratified analyses.
In the two-stage analyses, we first calculated the estimates for each study separately and in the second step we calculated the summary estimate over the results using random-effect meta-analysis. In the pooled analysis we pooled all available data and calculated the estimate, additionally adjusting the model for study. For comparison purposes, DWECS, IPAW, HHS and SLOSH are excluded from the results reported here, because only summary data were available for these studies. Supplementary figure 3. Country-specific estimates for the number of disease-free life-years after age 40 by BMI category for men. Men by country by BMI category for women. Non-melanoma skin cancer does not often cause major lasting disability. We performed a sensitivity analysis in which non-melanoma skin cancer was not included in the definition of disease-free years. The findings did not change from the main analyses in which all cancers were included, corresponding to WHO definition of major non-communicable diseases (supplemental 
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